ADDvise issues senior secured bonds

11-05-2023   Regulatory press release

ADDvise Group AB (publ) (the “Company”) announces today that it has successfully placed senior secured bonds in an amount of SEK 1,000 million under a framework of SEK 2,000 million with a tenor of 3 years (the “New Bonds” or the “Bond Issue”). The New Bonds will carry floating rate interest of STIBOR 3m plus 5.50 per cent per annum and were issued at par. The issue date for the New Bonds is expected to be 26 May 2023. The Bond Issue saw strong demand from a broad base of Nordic and international institutional investors and was significantly oversubscribed. Pareto Securities AB acted as Sole Global Coordinator and Joint Bookrunner and Skandinaviska Enskilda Banken AB (publ) acted as Joint Bookrunner in connection with the Bond Issue.

Subject to the New Bonds being successfully issued, the Company also intends to redeem in full its outstanding bond loan with ISIN SE0015222088 (the “Existing Bonds” and “Early Redemption”). The Existing Bonds will upon Early Redemption be redeemed at the redemption price of 103.625 per cent. of the nominal amount together with accrued but unpaid interest up to (and including) the redemption date. The Company intends to issue a notice of early redemption on 12 May 2023.


Important information

This information is information that ADDvise Group AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 11 May 2023 at 16:30 CEST.

For further information, please contact:

Rikard Akhtarzand, CEO

+46 765-25 90 71


Hanna Myhrman, General Counsel

+46 709-82 92 23


About ADDvise Group (publ)

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business - both geographically and product-wise. ADDvise Group's shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB is the Company's Certified Adviser. Additional information is available at


Latest press releases

ADDvise increases long-term financial targets


The Board of ADDvise Group AB has decided to update the long-term financial targets for EBITDA margin and revenue growth based on the strong financial performance and the visibility on the upcoming quarters. The EBITDA margin target has been increased from 20% to 28 % and the annual growth target from 25% to 30 %.…

ADDvise announces early redemption of existing bonds 2021/2024


ADDvise Group AB (publ) (the “Company”) announces today that it will redeem in full its outstanding bond loan with ISIN SE0015222088 (the “Bonds” and “Early Redemption”) subject to the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023. Provided that the conditions for Early Redemption are…

ADDvise extends the agreement with Laborie at a value of SEK 48 million


ADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The agreement is giving Laborie the right to sell Sonesta Medical’s urology- and gynecology patient positioning equipment and video fluoroscopy tables worldwide, with an exclusive right to distribute in USA and some European countries. Laborie commits to a minimum volume of…